The Patent Finder

Terms ending in 2034

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,889,671Compounds and Methods for Treating Bacterial Infections
In force
 · High confidence
Entasis Therapeutics Inc.In forceHigh confidence
US 9,187,495Compounds and Methods for Treating Bacterial Infections
In force
 · Medium confidence
Entasis Therapeutics Inc.In forceMedium confidence
US 10,556,939GLUCAGON/GLP-1 Agonists for the Treatment of Obesity
In force
 · High confidence
MedImmune LimitedIn forceHigh confidence
US 9,463,200Cell-Penetrating Oligonucleotides
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,066,979Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,375,432Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,718,806Quinazoline Inhibitors of Activating Mutant Forms of Epidermal Growth Factor Receptor
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,156,831Chemical Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,098,191Antibodies to Amyloid Beta
In force
 · Low confidence
MedImmune LimitedIn forceLow confidence
US 9,163,020Azaindole Compounds, Synthesis Thereof, and Methods of Using the Same
In force
 · High confidence
Foundation for Neglected Disease ResearchIn forceHigh confidence
11 more term ends in 2034 · Pro
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
Upgrade to Pro
16 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited